US Broker Ratings

GRAIL, Inc. (GRAL) Stock Analysis: Is the 92% Potential Upside Worth the Risk?

GRAIL, Inc. (GRAL), a prominent player in the healthcare sector, specifically in diagnostics and research, has been capturing the attention of investors, largely due to its..

Artivion, Inc. (AORT) Stock Analysis: Robust Revenue Growth and 37.51% Upside Potential

Investors seeking opportunities in the healthcare sector may find Artivion, Inc. (NYSE: AORT) an intriguing prospect. Specializing in medical devices, this U.S.-based company has demonstrated strong..

Wave Life Sciences Ltd. (WVE) Stock Analysis: 174% Potential Upside Sparks Investor Interest

Wave Life Sciences Ltd. (WVE) is capturing the attention of investors with its substantial potential upside of 174.48%, as indicated by the average target price of..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 170% Potential Upside in the Biotech Sector

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology space, is turning heads with an impressive potential upside of 170.76%. With a current stock price..

Astrana Health Inc. (ASTH) Stock Analysis: 46% Potential Upside Beckons Investors

Astrana Health Inc. (NASDAQ: ASTH) is emerging as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization..

Beam Therapeutics Inc. (BEAM) Stock Analysis: An Investor’s Guide to Potential 95.89% Upside

Beam Therapeutics Inc. (NASDAQ: BEAM) is a compelling prospect for investors keen on the biotechnology sector, particularly those interested in innovative genetic medicines. With a market..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Exploring a 100% Upside Potential

Ascentage Pharma Group International (AAPG), a China-based biotechnology firm, is drawing significant attention from investors thanks to its promising pipeline and a compelling potential upside of..

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 53% Upside Potential

Investors with an eye on the healthcare sector might want to consider ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a noteworthy player in the specialty and generic drug..

Novavax, Inc. (NVAX) Stock Analysis: Unpacking a 36.68% Potential Upside

As the global race for vaccine innovation continues, Novavax, Inc. (NASDAQ: NVAX) stands out as a key player in the biotechnology sector. With its focus on..

Bausch Health Companies Inc. (BHC)

⚠️ No article content returned.

..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 18.80% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biopharmaceutical company, is making waves in the healthcare sector with its focus on treating autoimmune diseases, including lupus nephritis...

Liquidia Corporation (LQDA) Stock Analysis: Exploring a Remarkable 3,054.60% Revenue Growth and 39.74% Upside Potential

Investors with a keen eye on the healthcare sector may find Liquidia Corporation (NASDAQ: LQDA) a compelling addition to their portfolios. As a biopharmaceutical enterprise specializing..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring the 86% Potential Upside and Analyst Confidence

Schrodinger, Inc. (NASDAQ: SDGR), a pivotal player in the healthcare sector, particularly within the health information services industry, is capturing attention with its innovative approach to..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a 210% Potential Upside in Biotech

For investors seeking opportunities in the healthcare sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling case. With an impressive potential upside of 210.34%, as indicated..

Innoviva, Inc. (INVA) Investor Outlook: Analyzing Growth Potential and a 49.89% Upside

Innoviva, Inc. (NASDAQ: INVA), a burgeoning biopharmaceutical player in the healthcare sector, has caught the attention of investors with its notable growth trajectory and promising market..

agilon health, inc. (AGL) Stock Analysis: Potential 58% Upside Amidst Revenue Growth

For investors navigating the volatile waters of healthcare stocks, agilon health, inc. (NYSE: AGL) presents a tantalizing opportunity. With a projected potential upside of 58.63%, this..

Opko Health, Inc. (OPK) Stock Analysis: A Glimpse into Potential 185% Upside

Opko Health, Inc. (NASDAQ: OPK), a Miami-based healthcare company, is making waves in the diagnostics and research industry. With a market capitalization of $913.56 million, Opko..

Organon & Co. (OGN) Stock Analysis: Potential 41.96% Upside Amid Healthcare Sector Challenges

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Organon & Co. (NYSE: OGN). With a market cap of $1.65..

Integra LifeSciences Holdings (IART) Stock Analysis: Unpacking the 65% Potential Upside in the Medical Devices Sector

Investors looking at the healthcare sector, particularly the medical devices industry, might find Integra LifeSciences Holdings Corporation (NASDAQ: IART) an intriguing prospect. Despite facing some headwinds,..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 40% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may want to keep a close eye on Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX). With a market capitalization of $3.76..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds